Arkolith/Insider Trading/SRNE/Form 4

Ji Henry

See Remarks, DirectorSorrento Therapeutics, Inc. (SRNE) · full profile →Form 4 · filed Aug 26, 2022
Net Buying
Open-Market Buys
$70K
Open-Market Sells
$0
Net Open-Market Flow
$70K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 26, 2022Buy(P)33K$2.11$70K2.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 26, 2022Sell(S)200$349.33$70K200

Transaction Codes

P
Open-market purchase
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-047741) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML